Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach test

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2985-2988

  Messina, Giusy ^a   Lissoni, P ^a   Bartolacelli, E ^a   Fumagalli, L ^a   Brivio, F ^a   Colombo, E ^b   Gardani, G S ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

IL 2; Immunotherapy; Renal cell cancer; Rorschach test

Indexed keywords

RECOMBINANT INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GENDER IDENTITY; HUMAN; KIDNEY CARCINOMA; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; PERSONALITY TEST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RORSCHACH TEST;

EID: 34547824322     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Regelson W and Pierpaoli W: Melatonin: a rediscovered antitumor hormone? Cancer Invest 5: 379-385, 1987.
2. Rubinow DR: Brain, behaviour and immunity: an interactive system. J Natl Cancer Inst Monogr 10: 79-82, 1990.
3. Maestroni JGM: The immunoneuroendocrine role of melatonin. J Pineal Res 14: 1-10, 1993.
4. Jankovic BD: Neuroimmunomodulation. From phenomenology to molecular evidence. Ann NY Acad Sci 741: 3-38, 1994.
5. Ursin H: The psychology in psychoneuroendocrinology. Psychoneuroendocrinology 23: 555-570, 1998.
6. Lissoni P, Cangemi P, Pirato D, Roselli MG, Rovelli F, Brivio F, Malugani F, Maestroni GJ, Conti A, Laudom M, Malysheva O and Giani L: A review on cancer-psychospiritual status interactions. Neuroendocrinol Lett 22: 175-180, 2001.
7. Guerrero JM and Reiter RJ: Melatonin-immune system relationships. Curr Topics Med Chem 2: 167-180, 2002.
8. Antoni MH: Psychoneuroimmunology and psychoneuroimmunology of cancer: plausible mechanism worth pursuing ? Brain, behavior and immunity 17: 84-91, 2003.
9. Lissoni P, Barni S, Ardizzoia A, Crispino S, Paolorossi F, Archili C, Vaghi M and Tancini G: Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer resistant to interferon-alpha. Eur J Cancer 28: 92-96, 1992.
10. Messina G, Lissoni P, Bartolacelli E, Tancini G, Villa S,Gardani GS and Brivio F: A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and the profile to Rorschach's test in early or advanced cancer patients. J Biol Regul Horn Agents 17: 322-326, 2003.
11. Rorschach H: Psychodiagnostics. Huber H (ed.), Bern, Stuttgart, Toronto: Verlag, 1921.
12. Stefanek M, McDonald G and Stephanie A: Hess Religion, spirituality and cancer: Current status and methodological challenges. Psycho-Oncology 14: 450-463, 2005.
13. Inman A, Kirsh KL and Passik SD: A pilot study to examine the relationship between boredom and spirituality in cancer patients. Gynecol Oncol 19: 133-134, 2005.
14. Laubmeier KK, Zakowski SG and Bair JP: The role of spirituality in the psychological adjustment to cancer: a test of the transactional model of stress and coping. Int J Behav Med 11: 48-55, 2004.
15. Messina G, Bartolacelli E, Lissoni P, Carta I, Brivio F, Fumagalli L and Gardani G: Psychological investigation in cancer patients: response to the Rorschach's test in relation to the histotype of tumors. The Italian J of Psychiatry and Behav Sciences 15: 59-63, 2005.
16. Mystakidou K, Tsilika E, Parpa E, Smyrnioti M and Vlahos L: Assessing spirituality and religiousness in advanced cancer patients. Am J Hosp Palliat Care 3: 457-463, 2006.